Latest First Analysis news

First Analysis acted as the exclusive financial advisor to The Benefits eXpert® (TBX®), an employee benefits technology company that offers an engagement, education and administrative platform, in its sale to Selerix, a provider of cloud-based benefits administration and communications solutions.

First Analysis acted as the exclusive financial advisor to Upfront Healthcare Services (Upfront), a next-generation patient engagement platform provider, in its sale to Health Catalyst (Nasdaq: HCAT), a provider of data and analytics technology and services to healthcare organizations.

Accel-KKR has acquired First Analysis portfolio company VisiQuate, a provider of advanced revenue cycle analytics, AI-powered workflow and automation solutions. The strategic partnership leverages Accel-KKR’s extensive resources and strategic expertise to accelerate product innovation and expand VisiQuate’s team.

First Analysis, a leading venture capital investor, has made a new investment in Applied StemCell (ASC), a contract development and manufacturing organization (CDMO) specializing in tailored cell and gene therapy solutions. First Analysis co-invested in ASC alongside QHP Capital.

First Analysis, a leading venture capital investor, has made a new investment in Sware, which provides a complete software validation solution for innovative life sciences companies. The investment will be used to bolster research and development of Sware’s computer systems validation (CSV) platform, Res_Q, to further streamline processes with artificial intelligence (AI), and to expand the company’s sales team so it can bring the platform to more organizations struggling with validation debt.

First Analysis acted as the exclusive financial advisor to Pharmacy Quality Solutions (PQS), a leading pharmacy-payer performance technology, in its sale to Innovaccer. The terms of the transaction were not disclosed.

First Analysis acted as the exclusive financial advisor to BHS, a provider of comprehensive mental health solutions through employee and student assistance programs, in its partnership with ReviveHealth and Eir Partners. The terms of the transaction were not disclosed.

First Analysis, a leading venture capital investor, has made a new investment in Dina, provider of digital network management and coordination solutions for the Medicare Advantage and managed Medicaid markets, with a particular focus on coordinating supplemental benefits and long-term services and supports (LTSS). The investment will support Dina’s go-to-market strategy as well as continued execution of the product roadmap. First Analysis led the $7 million Series B round.

Bestpass, a leading toll management and payment platform for commercial vehicles, has acquired First Analysis portfolio company Fleetworthy Solutions, a provider of fleet safety, compliance and risk management solutions. Bestpass will now offer a comprehensive suite of services that cover all aspects of tolling, compliance and safety for commercial fleets of all sizes.